Zeaxanthin and Valacyclovir drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Zeaxanthin (lutein) and Valacyclovir (valacyclovir hydrochloride). Common drug interactions include infusion site extravasation among females and insomnia among males.

The phase IV clinical study analyzes what interactions people have when they take Zeaxanthin and Valacyclovir. It is created by eHealthMe based on reports of 31 people who take the same drugs from the FDA, and is updated regularly.

What is Zeaxanthin?

Zeaxanthin has active ingredients of lutein. It is often used in macular degeneration. eHealthMe is studying from 1,687 Zeaxanthin users. Check the latest studies of Zeaxanthin.

What is Valacyclovir?

Valacyclovir has active ingredients of valacyclovir hydrochloride. It is often used in genital herpes. eHealthMe is studying from 42,107 Valacyclovir users. Check the latest studies of Valacyclovir.



On Jul, 30, 2026

31 people who take Zeaxanthin and Valacyclovir together, and have interactions are studied.

Zeaxanthin and Valacyclovir drug interactions.

What are the common drug interactions of Zeaxanthin and Valacyclovir, by gender? *:

female:

  1. Infusion site extravasation (flow of (blood or lymph) from infusion site)
  2. Metabolic disorder (an abnormal function and pattern of body fat. insulin resistance refers to the diminished ability of cells to respond to the action of insulin in promoting the transport of the sugar glucose, from blood into muscles and other tissues)
  3. Respiratory distress (difficulty in breathing)
  4. Dermatitis contact (skin reaction (dermatitis) resulting from exposure to allergens)
  5. Diarrhoea
  6. Fatigue (feeling of tiredness)
  7. Headache (pain in head)
  8. Lower respiratory tract infection
  9. Syncope (loss of consciousness with an inability to maintain postural tone)
  10. Visual impairment

male:

  1. Insomnia (sleeplessness)
  2. Platelet count decreased
  3. Conjunctivitis (pink eye)
  4. Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures)
  5. Erythema (redness of the skin)
  6. Eye infection
  7. Eyelid infection
  8. Fatigue (feeling of tiredness)
  9. Febrile neutropenia (fever with reduced white blood cells)
  10. Gallbladder disorder

What are the common drug interactions of Zeaxanthin and Valacyclovir, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Dermatitis contact (skin reaction (dermatitis) resulting from exposure to allergens)
  2. Lower respiratory tract infection
  3. Infection
  4. Sinusitis (inflammation of sinus)

40-49:

n/a

50-59:

  1. Balance disorder
  2. Epistaxis (bleed from the nose)
  3. Eye inflammation
  4. Fatigue (feeling of tiredness)
  5. Memory impairment
  6. Pruritus (severe itching of the skin)
  7. Pyrexia (fever)
  8. Vision blurred

60+:

  1. Syncope (loss of consciousness with an inability to maintain postural tone)
  2. Blood calcium increased
  3. Dental caries
  4. Depression
  5. Dyspnoea (difficult or laboured respiration)
  6. Erythema (redness of the skin)
  7. Fatigue (feeling of tiredness)
  8. Gait disturbance
  9. Headache (pain in head)
  10. Lymphocyte count decreased

What are the existing conditions these people have? *

  1. Burkitt Lymphoma (cancer of the lymphatic system): 6 people, 19.35%
  2. Multiple Myeloma (cancer of the plasma cells): 6 people, 19.35%
  3. Hypersensitivity: 5 people, 16.13%
  4. Stress And Anxiety: 5 people, 16.13%
  5. Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 4 people, 12.90%
  6. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 4 people, 12.90%
  7. Vulvovaginal Dryness: 3 people, 9.68%
  8. Blood Potassium Decreased: 3 people, 9.68%
  9. Immunodeficiency Common Variable: 3 people, 9.68%
  10. Nausea (feeling of having an urge to vomit): 3 people, 9.68%

* Approximation only. Some reports may have incomplete information.

Do you take Zeaxanthin and Valacyclovir?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Zeaxanthin and Valacyclovir:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Zeaxanthin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Valacyclovir:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Zeaxanthin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Valacyclovir and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on lutein and valacyclovir hydrochloride (the active ingredients of Zeaxanthin and Valacyclovir, respectively), and Zeaxanthin and Valacyclovir (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: